Psychiatry’s leadership is scrambling and fumbling in its effort to explain why it’s collusion with industry for pay is okay. Ever wondered how toxic psychoactive drugs that have been shown to be clinically insignificant have been catapulted into multi-billion dollar blockbuster sellers despite the fact that these drugs pose serious safety risks?
USA Today: Conflicts of Interest Bedevil Psychiatric Drug Research
Reading Time: < 1 minute
Recent Posts
- Cardiovascular Disease and Gut Microbiota April 17, 2024
- RCGP Introduces New Framework to Support GPs in Lifestyle Medicine April 16, 2024
- Sugar-sweetened drinks raise the risk of cardiovascular concerns, despite physical exercise April 4, 2024
- Clinical Education Receives Prestigious IHCAN Educator Award April 2, 2024
- Lifestyle and Nutrient Modulators of Neuroplasticity, Brain Health and Energy March 21, 2024
Recent Comments
- Monica Watson-Peck on Lifestyle and Nutrient Modulators of Neuroplasticity, Brain Health and Energy
- Ailsa Reed on Glandular Therapies: An Age-Old Solution for Modern Challenges and Chronic Disease
- Margaret on Glandular Therapies: An Age-Old Solution for Modern Challenges and Chronic Disease
- Ailsa Reed on Potent, Natural Fibrinolytic Enzymes Safely Reduce Clotting Risk
- Rachel on Potent, Natural Fibrinolytic Enzymes Safely Reduce Clotting Risk
Tags
A(H1N1)
allergies
antibiotics
antioxidants
autism
autoimmune
bacteria
bias
brain
CAM
cancer
cardiovascular
coeliac
cytokines
depression
detoxification
diet
dysbiosis
EFAs
evidence
gut
gut health
IBD
IBS
immune
immunity
inflammation
Lifestyle
microbiome
microbiota
mucosal
nutrition
obesity
pandemic
prevention
probiotics
regulatory T cells
research
sleep
swine flu
treatment
virus
Vitamin A
vitamin D
vitamins